FDA WARNING_LETTER - GLOBAL IMPORTS ORIGINS - March 12, 2026

The Food and Drug Administration (FDA) issued a warning letter to Global Imports Origins, located in Houston, Texas, following an inspection conducted from March 3 to March 12, 2026. This evaluation, which followed a previous inspection in 2023, aimed to determine the company’s compliance with the Foreign Supplier Verification Program (FSVP) requirements established under Section 805 of the Federal Food, Drug, and Cosmetic Act and associated regulations in 21 CFR part 1, subpart L. The primary violation identified was the company’s failure to develop, maintain, and follow an FSVP for its imported Red Pepper (Mixed Vegetables). Under the regulatory framework, importers are required to perform risk-based activities to verify that foreign-supplied food meets U.S. safety standards. Despite receiving a formal list of observations (Form FDA 483a) at the conclusion of the inspection, the company failed to provide a response or demonstrate that it had implemented the necessary safety protocols. The FDA has mandated that Global Imports Origins submit a written response within 15 working days of receiving the letter. This response must include specific documentation showing how the violations have been corrected, such as copies of the newly developed FSVP and evidence of its implementation. The agency warned that failure to address these issues promptly could result in serious consequences, including the refusal of food admissions into the United States and the placement of products on "detention without physical examination." Professional compliance is necessary to avoid further legal or administrative action by the FDA.